Spruce Biosciences Inc. (SPRB:NASDAQ) soared at $2.42, a gain of 93.6%. On Fri, Jan 06, 2023, SPRB:NASDAQ touched a New 2-Week High of $2.42. The stock appeared on our News Catalysts scanner on Fri, Jan 06, 2023 at 06:25 PM in the 'BIOTECH' category. From Fri, Dec 23, 2022, the stock recorded 75.00% Up Days and 44.44% Green Days
The stock spiked on Fri, Jan 06, 2023 at $3.38 with a volume of 63M+.
About Spruce Biosciences Inc. (SPRB:NASDAQ)
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders.
Top 10 Gainers:
- Moolec Science SA (MLEC:NASDAQ), 258.47%
- Swvl Holdings Corp (SWVL:NASDAQ), 115.36%
- Spruce Biosciences Inc. (SPRB:NASDAQ), 93.6%
- MultiMetaVerse Holdings Ltd Ord (MMV:NASDAQ), 82%
- MedAvail Holdings Inc. (MDVL:NASDAQ), 80.19%
- Golden Sun Education Group Limited (GSUN:NASDAQ), 77.78%
- MicroCloud Hologram Inc. (HOLO:NASDAQ), 53.72%
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 45.24%
- Oxbridge Re Holdings Limited (OXBR:NASDAQ), 43.51%
- CytomX Therapeutics, Inc. (CTMX:NASDAQ), 40.78%